169 related articles for article (PubMed ID: 33881940)
1. APLN: A potential novel biomarker for cervical cancer.
Chen Y; Lin X; Zheng J; Chen J; Xue H; Zheng X
Sci Prog; 2021; 104(2):368504211011341. PubMed ID: 33881940
[TBL] [Abstract][Full Text] [Related]
2. GJA1 Expression and Its Prognostic Value in Cervical Cancer.
Meng S; Fan X; Zhang J; An R; Li S
Biomed Res Int; 2020; 2020():8827920. PubMed ID: 33299882
[TBL] [Abstract][Full Text] [Related]
3. High APLN Expression Predicts Poor Prognosis for Glioma Patients.
Lv S; An Y; Dong H; Xie L; Zheng H; Cheng X; Zhang L; Teng T; Wang Q; Yan Z; Guo X
Oxid Med Cell Longev; 2022; 2022():8393336. PubMed ID: 36193059
[TBL] [Abstract][Full Text] [Related]
4. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
Zhang J; Wang X; Li G; He J; Lu Z; Yang Y; Jiang Y; Jiang L; Li F; Liu J
Biomed Res Int; 2021; 2021():6648078. PubMed ID: 33824874
[TBL] [Abstract][Full Text] [Related]
5. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
6. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
7. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
8. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
10. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
[TBL] [Abstract][Full Text] [Related]
11. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data.
Zhang X; Zhan D; Li Y; Wang H; Cheng C; Yao Y; Jia J
Med Sci Monit; 2020 May; 26():e921775. PubMed ID: 32392186
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
Zhengqi Q; Zezhi G; Lei J; He Q; Jinyao P; Ying A
Eur J Med Res; 2021 Jan; 26(1):9. PubMed ID: 33468235
[TBL] [Abstract][Full Text] [Related]
13. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
14. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
15. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Ye H; Guo X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
[TBL] [Abstract][Full Text] [Related]
16. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
17. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
18. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
[TBL] [Abstract][Full Text] [Related]
19. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer.
Wan Y; Zeng ZC; Xi M; Wan S; Hua W; Liu YL; Zhou YL; Luo HW; Jiang FN; Zhong WD
Hum Pathol; 2015 Feb; 46(2):295-303. PubMed ID: 25532941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
